Cargando…
Impact of p53 status on TRAIL-mediated apoptotic and non-apoptotic signaling in cancer cells
Due to their ability to preferentially induce cell death in tumor cells, while sparing healthy cells, TNF-related apoptosis-inducing ligand (TRAIL) and agonistic anti-TRAIL-R1 or anti-TRAIL-R2-specific antibodies are under clinical investigations for cancer-treatment. However, TRAIL-Rs may also indu...
Autores principales: | Willms, Anna, Schittek, Hella, Rahn, Sascha, Sosna, Justyna, Mert, Ufuk, Adam, Dieter, Trauzold, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448923/ https://www.ncbi.nlm.nih.gov/pubmed/30947287 http://dx.doi.org/10.1371/journal.pone.0214847 |
Ejemplares similares
-
Impact of Extracellular pH on Apoptotic and Non-Apoptotic TRAIL-Induced Signaling in Pancreatic Ductal Adenocarcinoma Cells
por: Hagelund, Sofie, et al.
Publicado: (2022) -
Endogenous TRAIL-R4 critically impacts apoptotic and non-apoptotic TRAIL-induced signaling in cancer cells
por: Rambow, Anna-Christina, et al.
Publicado: (2022) -
TRAIL Induces Nuclear Translocation and Chromatin Localization of TRAIL Death Receptors
por: Mert, Ufuk, et al.
Publicado: (2019) -
TRAIL-receptor 2—a novel negative regulator of p53
por: Willms, Anna, et al.
Publicado: (2021) -
TRAIL is involved in CpG ODN-mediated anti-apoptotic signals
por: LIM, EUN-JUNG, et al.
Publicado: (2011)